Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement

Journal of the American Society of Nephrology

Volumn 17, Issue 8, 2006, Pages 2264-2274

  De Lind Van Wijngaarden, Robert A F ^a   Hauer, Herbert A ^b   Wolterbeek, Ron ^a   Jayne, David R W ^d   Gaskin, Gill ^e   Rasmussen, Niels ^f   Noël, Laure Hélène ^g   Ferrario, Franco ^h   Waldherr, Rüdiger ⁱ   Hagen, E Christiaan ^c   Bruijn, Jan A ^a   Bajema, Ingeborg M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f Rigshospitalet   (Denmark)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h SAN CARLO BORROMEO HOSPITAL   (Italy)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ACUTE DISEASE; ADULT; AGE; AGED; ANCA ASSOCIATED VASCULITIS; ARTERIOSCLEROSIS; ARTICLE; ATROPHY; CELL INFILTRATION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 33746568460     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005080870     Document Type: Article

References (44)

1. Pettersson EE, Sundelin B, Heigl Z: Incidence and outcome of pauci-imrnune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 43: 141-149, 1995
2. Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 8: 314-322, 1997
3. Bajema IM, Hagen EC, van der Woude FJ, Bruijn JA: Wegener's granulomatosis: A meta-analysis of 349 literary case reports. J Lab Clin Med 129: 17-22, 1997
4. Watts RA, Scott DG: Epidemiology of the vasculitides. Curr Opin Rheumatol 15: 11-16, 2003
5. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
6. Jayne D: Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13: 48-55, 2001
7. Fauci AS, Haynes B, Katz P: The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89: 660-676, 1978
8. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 116: 488-498, 1992
9. Savage CO, Harper L, Adu D: Primary systemic vasculitis. Lancet 349: 553-558, 1997
10. Gayraud M, Guillevin L, Ie Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Analysis of four prospective trials including 278 patients. Arthritis Rheum 44: 666-675, 2001
11. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23-32, 1996
12. Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, Williams DG, Taube D, Brown CB, Hicks JA: Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome. Q J Med 53: 181-207, 1984
13. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56: 467-483, 1985
14. Weiss MA, Crissman JD: Segmental necrotizing glomerulonephritis: Diagnostic, prognostic, and therapeutic significance. Am J Kidney Dis 6: 199-211, 1985
15. Furlong TJ, Ibels LS, Eckstein RP: The clinical spectrum of necrotizing glomerulonephritis. Medicine 66:192-201, 1987
16. Croker BP, Lee T, Gunnells JC: Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: Primary crescentic and necrotizing glomerulonephritis. Hum Pathol 18: 38-44, 1987
17. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E: Wegener's granulomatosis with renal involvement: Patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 35: 139-147, 1991
18. Gans RO, Kuizinga MC, Goldschmeding R, Assmann K, Huysmans FT, Gerlag PG, Donker AJ, Hoorntje SJ: Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 64: 182-188, 1993
19. Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, De Jong PE, Tervaert JW: Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 9: 1915-1923, 1998
20. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients. Kidney Int 62: 1732-1742, 2002
21. Jayne DR, Rasmussen N: Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 72: 737-747, 1997
22. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Ludemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ: Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53: 743-753, 1998
23. Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56: 1751-1758, 1999
24. Bajema IM, Hagen EC, Hansen BE, Hermans J, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA: The renal histopathology in systemic vasculitis: An international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 11: 1989-1995, 1996
25. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
26. Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ: Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116: 114-123, 1992
27. Peters DK, Rees AJ, Lockwood CM, Pusey CD: Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc 14: 513-521, 1982
28. Senn S, Stevens L, Chaturvedi N: Repeated measures in clinical trials: Simple strategies for analysis using summary measures. Stat Med 19: 861-877, 2000
29. Hauer HA, Bajema IM, Hagen EC, Noel LH, Ferrario F, Waldherr R, van Houwelingen HC, Lesavre P, Sinico RA, van der WF, Gaskin G, Verburgh CA, de Heer E, Bruijn JA: Long-term renal injury in ANCA-associated vasculitis: An analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 17: 587-596, 2002
30. Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63: 670-677, 2003
31. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR: Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 41: 776-784, 2003
32. Dringenberg C, Apenberg S, Andrassy K: p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement. Adv Exp Med Biol 336: 445-447, 1993
33. Bock HA: Pathogenesis of acute renal failure: New aspects. Nephron 76: 130-142, 1997
34. Baelde HJ, Eikmans M, Van Vliet AI, Bergijk EC, de Heer E, Bruijn JA: Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: The role of TGFbeta and IL-4. J Pathol 204: 248-257, 2004
35. Abo-Zenah H, Katsoudas S, Wild G, de Takats D, Shortland J, Brown CB, El Nahas AM: Early human renal allograft fibrosis: Cellular mediators. Nephron 91:112-119, 2002
36. Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT: Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20: 96-104, 2005
37. Haroun MK, Stone JH, Nair R, Racusen L, Hellmann DB, Eustace JA: Correlation of percentage of normal glomeruli with renal outcome in Wegener's granulomatosis. Am J Nephrol 22: 497-503, 2002
38. Aasarod K, Bostad L, Hammerstrom J, Jorstad S, Iversen BM: Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. Nephrol Dial Transplant 16: 953-960, 2001
39. Kapitsinou PP, Ioannidis JP, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM: Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 41: 29-37, 2003
40. Vergunst CE, van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM: An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 41: 532-538, 2003
41. Wilkowski MJ, Velosa JA, Holley KE, Offord KP, Chu CP, Torres VE, McCarthy JT, Donadio JV Jr, Wagoner RD: Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney M 36: 1133-1141, 1989
42. Hasegawa M, Watanabe A, Takahashi H, Takahashi K, Kasugai M, Kawamura N, Kushimoto H, Murakami K, Tomita M, Nabeshima K, Oohashi A, Kondou F, Ooshima H, Hiki Y, Sugiyama S: Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors. Ther Apher Dial 9: 297-302, 2005
43. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD: ANCA-associated vasculitis with renal involvement: An outcome analysis. Nephrol Dial Transplant 19: 1403-1411, 2004
44. Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H: Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody-(MPO-ANCA) associated glomerulonephritis. Clin Nephrol 55: 275-281, 2001